Publication | Closed Access

Rationale and design of AVERROES: Apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment

ThrombosisAcetylsalicylic AcidCardiovascular DiseaseMedicineAtrial Fibrillation PatientsCardiovascular PharmacologyPharmacotherapyPlatelet AntagonistPharmacologyAnticoagulantAtherosclerosis